Vir Biotechnology, Inc.
ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME
Last updated:
Abstract:
The instant disclosure provides antibodies and antigen-binding fragments thereof that can bind to a SARS-CoV-2 antigen and, in certain embodiments, are capable of neutralizing a SARS-CoV-2 infection. Also provided are polynucleotides that encode an antibody or antigen-binding fragment, vectors and host cells that comprise a polynucleotide, pharmaceutical compositions, and methods of using the presently disclosed antibodies, antigen-binding fragments, polynucleotides, vectors, host cells, and compositions to treat or diagnose a SARS-CoV-2 infection.
Status:
Application
Type:
Utility
Filling date:
25 Feb 2021
Issue date:
26 Aug 2021